Pharming Group N.V. Second quarter and first half 2024 financial results and business update August 1, 2024 NASDAQ: PHAR | EURONEXT Amsterdam: PHARM SPEAKERS Sijmen de Vries, MD Stephen Toor Chief Executive Officer Chief Commercial Officer Anurag Relan, MD Chief Medical Officer Jeroen Wakkerman Chief Financial Officer Forward-looking statements This presentation may contain forward-looking statements. Forward-looking statements are statements of future expectations that are based on management's current exp ...